Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Evolution of biofilm-adapted gene expression profiles in lasR-deficient clinical Pseudomonas aeruginosa isolates

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pseudomonas aeruginosa post-translational responses to elevated c-di-GMP levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pseudomonas aeruginosa Is More Tolerant Under Biofilm Than Under Planktonic Growth Conditions: A Multi-Isolate Survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Monique Donnert
  • Sarah Elsheikh
  • Alejandro Arce-Rodriguez
  • Vinay Pawar
  • Peter Braubach
  • Danny Jonigk
  • Axel Haverich
  • Siegfried Weiss
  • Mathias Müsken
  • Susanne Häussler
Vis graf over relationer

Embedded in an extracellular matrix, biofilm-residing bacteria are protected from diverse physicochemical insults. In accordance, in the human host the general recalcitrance of biofilm-grown bacteria hinders successful eradication of chronic, biofilm-associated infections. In this study, we demonstrate that upon addition of promethazine, an FDA approved drug, antibiotic tolerance of in vitro biofilm-grown bacteria can be abolished. We show that following the addition of promethazine, diverse antibiotics are capable of efficiently killing biofilm-residing cells at minimal inhibitory concentrations. Synergistic effects could also be observed in a murine in vivo model system. PMZ was shown to increase membrane potential and interfere with bacterial respiration. Of note, antibiotic killing activity was elevated when PMZ was added to cells grown under environmental conditions that induce low intracellular proton levels. Our results imply that biofilm-grown bacteria avoid antibiotic killing and become tolerant by counteracting intracellular alkalization through the adaptation of metabolic and transport functions. Abrogation of antibiotic tolerance by interfering with the cell's bioenergetics promises to pave the way for successful eradication of biofilm-associated infections. Repurposing promethazine as a biofilm-sensitizing drug has the potential to accelerate the introduction of new treatments for recalcitrant, biofilm-associated infections into the clinic.

OriginalsprogEngelsk
TidsskriftPLoS pathogens
Vol/bind16
Udgave nummer12
Sider (fra-til)e1009126
ISSN1553-7366
DOI
StatusUdgivet - dec. 2020

ID: 62403710